Publications by authors named "Muskan Khelani"
BMC Cardiovasc Disord
December 2024
Article Synopsis
- Dapagliflozin is a promising treatment for Acute Heart Failure (AHF), showing benefits in reducing cardiovascular mortality and hospital readmissions compared to traditional therapies.
- A systematic review of five randomized controlled trials indicated that dapagliflozin significantly lowered in-hospital cardiovascular mortality rates and 30-day hospital readmissions without impacting hospital stay length or hypotension incidents.
- The research followed established protocols for data extraction and quality assessment, demonstrating a notable weight change in patients receiving dapagliflozin, reinforcing its efficacy as a treatment option in AHF.
